Beklager ikke på norsk For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

This collaboration originated as a subproject of the Norwegian Cancer Genomics Consortium (NCGC), which also has projects on 8 other cancer types. It has since been extended by grants from the Cancer Society “Krafttak mot Kreft” charity, Radiumhospitalets legater, South East Health Authorities and others.

Oslo University Hospital  – Norwegian Radium Hospital treats about 80% of Norwegian patients, has an active sarcoma research community, and houses the National Competence Service for Sarcomas. I have worked there for 30 years, and established the Mesenchymal Cancer Biology Group, now taken over by Dr Jørgen Wesche, as I moved to Bergen University. However, the NoSarC collaboration continues, and in Oslo Jørgen takes care of the cell biology aspects, Leonardo A Meza-Zepeda continues the studies of sarcoma genomics, Dr Kjetil Boye is responsible for sarcoma oncology, Dr Bodil Bjerkehagen is the sarcoma reference pathologist, and from Bergen I try to pull the plans through.

We collaborate closely with the Pediatric Cancer Group at OUH – Rikshospitalet, and the sarcoma clinics at Haukeland University Hospital, St Olav University Hospital, and the University Hospital of Northern Norway.

We also have a number of international collaborations for specific subprojects, see for more information.

Current consortium members:

Haukeland Sarcoma Centre (Nina Jebsen)

Haukeland Centre for hereditary cancer (Hildegunn Vetti)

UNN University Hospital of Northern Norway (Eivind Smeland)

OUS- Radiumhospitalet Sarcoma group (Kirsten Sundby-Hall, Kjetil Boye, Bodil Bjerkehagen, Leonardo Meza-Zepeda, Ola Myklebost)

OUS – Rikshospitalet Pediatric Oncology (Heidi Glosli)

St Olavs University Hospital Sarcoma Group (Heidi Knobel)

National Competence Centre for Sarcomas (Olga Zaikova)

Comments are closed.